Encapsulation and subsequent freeze-drying of Lactobacillus reuteri CRL 1324 for its potential inclusion in vaginal probiotic formulations

European Journal of Pharmaceutical Sciences

Volumn 79, Issue , 2015, Pages 87-95

  Juárez Tomás, María Silvina ^a   De Gregorio, Priscilla Romina ^a   Leccese Terraf, María Cecilia ^a   Nader Macías, María Elena Fátima ^a  

^a CENTRO DE REFERENCIA PARA LACTOBACILOS CERELA CONICET   (Argentina)

Author keywords

Activity maintenance; Encapsulation; Freeze drying; Simulated vaginal fluid survival; Storage; Vaginal probiotic

Indexed keywords

GELLAN; PROBIOTIC AGENT; XANTHAN; MICROCAPSULE;

ARTICLE; BACTERIAL CELL; BACTERIAL GROWTH; BACTERIAL SURVIVAL; BACTERIAL VIABILITY; BACTERIUM CULTURE; BIOFILM; CELL ENCAPSULATION; CELL SUSPENSION; CELL VIABILITY; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG FORMULATION; DRUG RELEASE; DRUG STABILITY; DRUG STORAGE; FREEZE DRYING; GELATION; GENITAL SYSTEM; GROWTH INHIBITION; HUMAN; LACTOBACILLUS REUTERI; LACTOBACILLUS REUTERI CRL 1324; MICROCAPSULE; NONHUMAN; PRIORITY JOURNAL; ROOM TEMPERATURE; SCANNING ELECTRON MICROSCOPY; STORAGE TEMPERATURE; STREPTOCOCCUS AGALACTIAE; SURVIVAL RATE; VAGINA DISCHARGE; VAGINA FLORA; FEMALE; GROWTH, DEVELOPMENT AND AGING; INTRAVAGINAL DRUG ADMINISTRATION; METABOLISM; MICROBIOLOGY; STREPTOCOCCAL INFECTIONS; VAGINA;

ADMINISTRATION, INTRAVAGINAL; CAPSULES; FEMALE; FREEZE DRYING; HUMANS; LACTOBACILLUS REUTERI; PROBIOTICS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; VAGINA;

EID: 84942256483     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2015.08.010     Document Type: Article

References (40)

1. A. Alli Preparation and characterization of a coacervate extended-release microparticulate delivery system for Lactobacillus rhamnosus Int. J. Nanomedicine 6 2011 1699 1707
2. S. Borges, and P. Teixeira Pediococcus pentosaceus SB83 as a potential probiotic incorporated in a liquid system for vaginal delivery Benefic. Microbes 5 2014 421 426
3. S. Borges, P. Costa, J. Silva, and P. Teixeira Effects of processing and storage on Pediococcus pentosaceus SB83 in vaginal formulations: lyophilized powder and tablets Biomed. Res. Int. 2013 2013 680767
4. P.R. De Gregorio, M.S. Juárez Tomás, M.C. Leccese Terraf, and M.E. Nader-Macias In vitro and in vivo effects of beneficial vaginal lactobacilli on pathogens responsible for urogenital tract infections J. Med. Microbiol. 63 2014 685 696
5. P.R. De Gregorio, M.S. Juárez Tomás, M.C. Leccese Terraf, and M.E.F. Nader-Macías Preventive effect of Lactobacillus reuteri CRL1324 on Group B Streptococcus vaginal colonization in an experimental mouse model J. Appl. Microbiol. 118 2015 1034 1047
6. J.C. De Man, M. Rogosa, and M.E. Sharpe A medium for the cultivation of lactobacilli J. Appl. Bacteriol. 23 1960 130 135
7. W.K. Ding, and N.P. Shah Effect of various encapsulating materials on the stability of probiotic bacteria J. Food Sci. 74 2009 100 107
8. K.J. Domig, H. Kiss, L. Petricevic, H. Viernstein, F. Unger, and W. Kneifel Strategies for the evaluation and selection of potential vaginal probiotics from human sources: an exemplary study Benefic. Microbes 5 2014 263 272
9. E. du Toit, S. Vesterlund, M. Gueimonde, and S. Salminen Assessment of the effect of stress-tolerance acquisition on some basic characteristics of specific probiotics Int. J. Food Microbiol. 165 2013 51 56
10. A. Endo, J. Teräsjärvi, and S. Salminen Food matrices and cell conditions influence survival of Lactobacillus rhamnosus GG under heat stresses and during storage Int. J. Food Microbiol. 174 2014 110 112
11. FAO/WHO Evaluation of health and nutritional properties of powder milk and live lactic acid bacteria Food and Agriculture Organization of the United Nations and World Health Organization Expert Consultation Report 2001 (http://www.fao.org/es/ESN/Probio/probio.htm)
12. C.L. Gerez, G. Font de Valdez, M.L. Gigante, and C.R.F. Grosso Whey protein coating bead improves the survival of the probiotic Lactobacillus rhamnosus CRL 1505 to low pH Lett. Appl. Microbiol. 54 2012 552 556
13. C. Hill, F. Guarner, G. Reid, G.R. Gibson, D.J. Merenstein, B. Pot, L. Morelli, R.B. Canani, H.J. Flint, S. Salminen, P.C. Calder, and M.E. Sanders Expert consensus document: the International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic Nat. Rev. Gastroenterol. Hepatol. 11 2014 506 514
14. Human Microbiome Project Consortium Structure, function and diversity of the healthy human microbiome Nature 486 2012 207 214
15. M.A. Islam, C.H. Yun, Y.J. Choi, and C.S. Cho Microencapsulation of live probiotic bacteria J. Microbiol. Biotechnol. 20 2010 1367 1377
16. M.L. Jiménez-Pranteda, D. Poncelet, M.E. Nader-Macías, A. Arcos, M. Aguilera, M. Monteoliva-Sánchez, and A. Ramos-Cormenzana Stability of lactobacilli encapsulated in various microbial polymers J. Biosci. Bioeng. 113 2012 179 184
17. M.S. Juárez Tomás, and M.E. Nader-Macías Effect of a medium simulating vaginal fluid on the growth and expression of beneficial characteristics of potentially probiotic lactobacilli A. Méndez-Vilas, Communicating Current Research and Educational Topics and Trends in Applied Microbiology Microbiology Book Series 2007 Formatex Badajoz 732 739
18. M.S. Juárez Tomás, V.S. Ocaña, B. Wiese, and M.E. Nader-Macías Growth and lactic acid production by vaginal Lactobacillus acidophilus CRL 1259, and inhibition of uropathogenic Escherichia coli J. Med. Microbiol. 52 2003 1117 1124
19. M.S. Juárez Tomás, E. Bru, G. Martos, and M.E. Nader-Macías Stability of freeze-dried vaginal Lactobacillus strains in the presence of different lyoprotectors Can. J. Microbiol. 55 2009 544 552
20. M.S. Juárez Tomás, C.I. Saralegui Duhart, P.R. De Gregorio, E. Vera Pingitore, and M.E. Nader-Macías Urogenital pathogen inhibition and compatibility between vaginal Lactobacillus strains to be considered as probiotic candidates Eur. J. Obstet. Gynecol. Reprod. Biol. 159 2011 399 406
21. M.C. Leccese Terraf, M.S. Juárez Tomás, M.E. Nader-Macías, and C. Silva Screening of biofilm formation by beneficial vaginal lactobacilli and influence of culture media components J. Appl. Microbiol. 113 2012 1517 1529
22. M.C. Leccese Terraf, L.M. Mendoza, M.S. Juárez Tomás, C. Silva, and M.E. Nader-Macías Phenotypic surface properties (aggregation, adhesion and biofilm formation) and presence of related genes in beneficial vaginal lactobacilli J. Appl. Microbiol. 117 2014 1761 1772
23. M.J. Martín Villena, M.E. Morales Hernández, V. Gallardo Lara, and M.A. Ruiz Martínez Técnicas de microencapsulación: una propuesta para microencapsular probióticos Ars Pharm. 50 2009 43 50
24. M.J. Martín Villena, M.E. Morales Hernández, P. Gálvez Martín, B. Clares Naveros, and M.A. Ruiz Martínez Desarrollo de una técnica para la microencapsulación de probióticos ARS Pharm. 51 Suppl. 3 2010 479 484
25. G.I. Martos, C.J. Minahk, G. Font de Valdez, and R. Morero Effects of protective agents on membrane fluidity of freeze-dried Lactobacillus delbrueckii ssp. bulgaricus Lett. Appl. Microbiol. 45 2007 282 288
26. P. Mastromarino, B. Vitali, and L. Mosca Bacterial vaginosis: a review on clinical trials with probiotics New Microbiol. 36 2013 229 238
27. C. Muller, V. Busignies, V. Mazel, C. Forestier, A. Nivoliez, and P. Tchoreloff Mechanistic approach to stability studies as a tool for the optimization and development of new products based on L. rhamnosus Lcr35® in compliance with current regulations PLoS One 8 2013 e79041
28. C. Muller, V. Mazel, C. Dausset, V. Busignies, S. Bornes, A. Nivoliez, and P. Tchoreloff Study of the Lactobacillus rhamnosus Lcr35® properties after compression and proposition of a model to predict tablet stability Eur. J. Pharm. Biopharm. 88 2014 787 794
29. V.S. Ocaña, E. Bru, A.P. de Ruiz Holgado, and M.E. Nader-Macías Surface characteristics of lactobacilli isolated from human vagina J. Gen. Appl. Microbiol. 45 1999 203 212
30. D. Pliszczak, S. Bourgeois, C. Bordes, J.P. Valour, M.A. Mazoyer, A.M. Orecchioni, E. Nakache, and P. Lantéri Improvement of an encapsulation process for the preparation of pro- and prebiotics-loaded bioadhesive microparticles by using experimental design Eur. J. Pharm. Sci. 44 2011 83 92
31. P. Raibaud, J.V. Galpin, R. Ducluzeau, G. Mocquot, and G. Oliver Le genre Lactobacillus dans le tuve digestif du rat. I. Caractères de souches homofermentaires isolées de rats holo et gnotoxéniques Ann. Microbiol. (Paris) 124 1973 83 109
32. G. Reid Modulating the vaginal microbiome: the need for a bridge between science and practice Semin. Reprod. Med. 32 2014 28 34
33. C. Remuñán López, and M.J. Alonso Fernández Microencapsulación de medicamentos J.L. Vila Jato, Tecnología Farmacéutica. Volumen I: Aspectos Fundamentales de los Sistemas Farmacéuticos y Operaciones Básicas Vol. I 1997 Síntesis SA Madrid 577 609
34. C. Santivarangkna, B. Higl, and P. Foerst Protection mechanisms of sugars during different stages of preparation process of dried lactic acid starter cultures Food Microbiol. 25 2008 429 441
35. M. Savini, C. Cecchini, M.C. Verdenelli, S. Silvi, C. Orpianesi, and A. Cresci Pilot-scale production and viability analysis of freeze-dried probiotic bacteria using different protective agents Nutrients 2 2010 330 339
36. H.K. Solanki, D.D. Pawar, D.A. Shah, V.D. Prajapati, G.K. Jani, A.M. Mulla, and P.M. Thakar Development of microencapsulation delivery system for long-term preservation of probiotics as biotherapeutics agent Biomed. Res. Int. 2013 2013 620719
37. W. Sun, and M.W. Griffiths Survival of bifidobacteria in yogurt and simulated gastric juice following immobilization in gellan-xanthan beads Int. J. Food Microbiol. 61 2000 17 25
38. M.C. Verdenelli, M.M. Coman, C. Cecchini, S. Silvi, C. Orpianesi, and A. Cresci Evaluation of antipathogenic activity and adherence properties of human Lactobacillus strains for vaginal formulations J. Appl. Microbiol. 116 2014 1297 1307
39. F. Weinbreck, I. Bodnár, and M.L. Marco Can encapsulation lengthen the shelf-life of probiotic bacteria in dry products? Int. J. Food Microbiol. 136 2010 364 367
40. S.S. Witkin The vaginal microbiome, vaginal anti-microbial defense mechanisms and the clinical challenge of reducing infection-related preterm birth BJOG 122 2015 213 218